Group One Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Group One Trading’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,041	Closed	-$942K	–	7599
2024 Q2	$942K	Sell	23,041 -3,976	-15%	-$166K	﹤0.01%	2033
2024 Q1	$1.14M	Buy	27,017 +6,932	+35%	+$291K	﹤0.01%	1970
2023 Q4	$852K	Buy	+20,085	New	+$577K	﹤0.01%	2606
2022 Q3	–	Sell	-3,063	Closed	-$91.2K	–	8435
2022 Q2	$81K	Buy	+3,063	New	+$87K	﹤0.01%	5177

Other funds holding CERE

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Group One Trading's CERE Position: Q3 2024 in Review

Group One Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 23,041 shares — an estimated $942K sold.

Group One Trading first reported a position in CERE in Q2 2022 and held it in 4 quarters. The position peaked at $1.14M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Group One Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Group One Trading sold 23,041 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $942K.
Group One Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Group One Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.14M in Q1 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.